SCHEMBL8367985

SCHEMBL8367985

O=C(O)CC1CCNc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.45
▸ FFAR1 O14842 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ BCHE P06276 1/20 0.41
▸ PPARD Q03181 2/20 0.39
▸ CCKBR P32239 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ BDKRB1 P46663 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500008 0.86 HSD17B10 (0.41) EGFRBCHEHSD17B10BDKRB1
SCHEMBL9586168 0.84 EGFR (0.48) EGFRBCHE
SCHEMBL3958089 0.83 EGFR (0.47) EGFRTP53L3MBTL1PPARDCCKBR
SCHEMBL2605809 0.83 EGFR (0.47) EGFRTP53L3MBTL1PPARDCCKBR
SCHEMBL3964364 0.83 EGFR (0.47) EGFRTP53L3MBTL1PPARDCCKBR
SCHEMBL6244927 0.83 SMN1; SMN2 (0.51) HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL9124959 0.82 EGFR (0.50) EGFRBCHEALDH1A1SMN1; SMN2
SCHEMBL5410564 0.80 PARP3 (0.43) EGFRFFAR1TP53L3MBTL1PPARD
SCHEMBL3694236 0.80 BCHE (0.39) BCHECCKBRBDKRB1
SCHEMBL26644922 0.80 CYP1A2 (0.47) L3MBTL1BCHEHSD17B10ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105934246-A Tetrahydroquinoline compositions as BET bromodomain inhibitors 福马疗法公司 2016-09-07 — — CN claimed
CN-105934246-A Tetrahydroquinoline compositions as BET bromodomain inhibitors 福马疗法公司 2016-09-07 — — CN disclosed
WO-1999051590-A1 SUBSTITUTED INDOLINONES AS KINASE INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-14 — — WO disclosed
EP-0364327-B1 QUINOLINONE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPY SYNTHELABO (FR) 1992-01-15 — — EP disclosed
EP-0364327-A1 Quinolinone derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1990-04-18 — — EP disclosed
Send feedback